Europe Microbial Api Market Size & Outlook, 2023-2030

The microbial api market in Europe is expected to reach a projected revenue of US$ 19,750.9 million by 2030. A compound annual growth rate of 7.5% is expected of Europe microbial api market from 2024 to 2030.
Revenue, 2023 (US$M)
$11,943.8
Forecast, 2030 (US$M)
$19,750.9
CAGR, 2024 - 2030
7.4%
Report Coverage
Europe

Europe microbial api market highlights

  • The Europe microbial api market generated a revenue of USD 11,943.8 million in 2023.
  • The market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
  • In terms of segment, mammalian was the largest revenue generating host in 2023.
  • Mammalian is the most lucrative host segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.

Europe data book summary

Market revenue in 2023USD 11,943.8 million
Market revenue in 2030USD 19,750.9 million
Growth rate7.5% (CAGR from 2023 to 2030)
Largest segmentMammalian
Fastest growing segmentMammalian
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationMammalian, Bacterial, Fungal
Key market players worldwideMerck & Co Inc, DSM, CSPC Pharmaceutical Group Ltd, Teva Pharmaceutical Industries Ltd, Lonza Group Ltd, Takeda Pharmaceutical Co Ltd, Kolon Life Science, Shandong Lukang Pharmaceutical Group

Other key industry trends

  • In terms of revenue, Europe region accounted for 20.2% of the global microbial api market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Europe is the fastest growing regional market and is projected to reach USD 19,750.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Microbial API Market Companies

Name Profile # Employees HQ Website

Europe microbial api market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial api market will help companies and investors design strategic landscapes.


Mammalian was the largest segment with a revenue share of 47.4% in 2023. Horizon Databook has segmented the Europe microbial api market based on mammalian, bacterial, fungal covering the revenue growth of each sub-segment from 2018 to 2030.


  • Europe Microbial API Host Outlook (Revenue, USD Million, 2018-2030)
    • Mammalian
    • Bacterial
    • Fungal
  • Europe Microbial API Type Outlook (Revenue, USD Million, 2018-2030)
    • Antibody
    • Peptide
    • Protein
    • Small Molecule
    • Vaccine
  • Europe Microbial API Site Outlook (Revenue, USD Million, 2018-2030)
    • In-house
    • Outsourced
  • Europe Microbial API End Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical Companies
    • Biopharmaceutical Companies
    • Others
  • Europe Microbial API Molecule Outlook (Revenue, USD Million, 2018-2030)
    • Innovative
    • Generic

Reasons to subscribe to Europe microbial api market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe microbial api market databook

  • Our clientele includes a mix of microbial api market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe microbial api market , including forecasts for subscribers. This continent databook contains high-level insights into Europe microbial api market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe microbial api market size, by country, 2018-2030 (US$M)

Europe Microbial API Market Outlook Share, 2023 & 2030 (US$M)

Europe microbial api market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more